John Daly, CEO of CareCloud, Inc. (NASDAQ:CCLD), recently sold 5,000 shares of the company’s stock, according to a filing with the Securities and Exchange Commission. The health technology company, currently valued at approximately USD 59 million, has shown outstanding results with a return of 141% over the past year. According to InvestingPro analysis, the stock is trading close to its fair value. The transaction, dated December 31, 2024, was executed at a price of $3.87 per share, for a total value of $19,350. Following this sale, Daly retains ownership of 61,750 shares of the company. InvestingPro subscribers have access to 12 additional key insights on CCLD, including a detailed analysis of its financial health, which is currently rated EXCELLENT with an overall rating of 3.16.
In other recent news, healthcare technology provider CareCloud experienced a downgrade from Roth/MKM, moving from a Buy rating to Neutral due to weak growth projections in 2025. Despite recent cost-cutting measures, the company’s growth outlook remains unimpressive, leading to a reduction in revenue forecasts. This comes despite third-quarter revenue of $28.5 million, which met analysts’ expectations, and an increase in the company’s adjusted EBITDA to $6.8 million.
CareCloud’s third-quarter earnings report also revealed a slight drop in revenue, to $28.5 million from $29.3 million a year earlier. However, the company’s adjusted EBITDA rose significantly year-over-year to $6.8 million, and free cash flow improved dramatically, reaching $10.3 million.
The company paid off its credit facility in full and announced plans to resume paying dividends in March 2025. CareCloud also reported positive GAAP net income of $3.1 million, up from a loss of $2.7 million USD in the third quarter of 2023. These are recent developments that are shaping the trajectory of the company’s business.
This article was generated with the support of artificial intelligence and reviewed by an editor. See our T&C for more information.
